“…Such alterations may lead to an increased propensity for degeneration, which could be initiated either in conjunction with other factors or by accumulation of defects over longer periods of time. First indications for such links have recently emerged: For instance, subtle alterations of tubulin PTMs have been detected in brain tissue of Alzheimer's disease patients (Zhang et al, 2015;Vu et al, 2017), and another deglutamylase, CCP2 (encoded by the AGBL2 gene), was linked to Alzheimer's disease by genome-wide association (Lambert et al, 2013) and proteome (Seyfried et al, 2017) studies. Although CCP2 is a deglutamylase with yet unknown functions, and knockout mice show no obvious defects in the nervous system (Tort et al, 2014), CCP2 dysfunction might lead to small alterations in polyglutamylation, resulting in accumulation of neuronal defects over the much longer lifespan of humans, and thus to late-onset neurodegeneration.…”